Je was op zoek naar: fenobarbitala (Sloveens - Engels)

med jemanjem holne kisline ne uporabljajte fenobarbitala.
do not take any phenobarbital while you are on cholic acid.

na farmakodinamiko klopidogrela tudi ni pomembno vplivalo sočasno jemanje fenobarbitala ali estrogena.
furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the coadministration of phenobarbital or oestrogen.

↑ ali ↓ fenobarbitala indukcija cyp3a s fenobarbitalom in zaviranje cyp3a s telaprevirjem
↑ or ↓ phenobarbital induction of cyp3a by phenobarbital, and inhibition of cyp3a by telaprevir

sočasna uporaba fenobarbitala in holne kisline (glejte poglavje 4.5).
concomitant use of phenobarbital with cholic acid (see section 4.5).

poleg tega na farmakodinamično aktivnost klopidogrela sočasna uporaba fenobarbitala ali estrogena ni pomembno vplivala.
furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the co-administration of phenobarbital or oestrogen.

zaradi inducirajočega učinka fenitoina/fenobarbitala zmanjšanja izpostavljenosti zdravilu reyataz ne moremo izključiti.
due to phenytoin/phenobarbital inducing effect, a reduction in reyataz exposure cannot be ruled out.

poleg tega na farmakodinamično aktivnost klopidogrela ni pomembno vplivala sočasna uporaba fenobarbitala, cimetidina ali estrogena.
furthermore, the pharmacodynamic activity of clopidogrel was not significantly influenced by the co-administration of phenobarbital, cimetidine or oestrogen.

ritonavir lahko zaradi indukcije cyp2c9 in cyp2c19 zmanjša vrednosti fenitoina in/ali fenobarbitala v plazmi.
ritonavir may decrease plasma levels of phenytoin and/or phenobarbital due to cyp2c9 and cyp2c19 induction.

zaradi inducirajočega učinka fenitoina/fenobarbitala zmanjšanja izpostavljenosti zdravilu reyataz/ritonavir ne moremo izključiti.
due to phenitoine/phenobarbital inducing effect, a reduction in reyataz/ritonavir exposure cannot be ruled out

vpliva drugih induktorjev (npr. fenitoina, karbamazepina, fenobarbitala, šentjanževke) ni mogoče izključiti.
it cannot be excluded that other inducers (e.g. phenytoin, carbamazepine, phenobarbital, st john’s wort) may also affect rosiglitazone exposure.

ta analiza tudi ni pokazala klinično pomembnega učinka induktorjev (fenitoina, karbamazepina in fenobarbitala) na očistek retigabina.
this analysis also showed no clinically significant effect of the inducers (phenytoin, carbamazepine and phenobarbital) on retigabine clearance.

pri sočasni uporabi z efavirenzem obstaja možnost zmanjšanja ali povečanja plazemskih koncentracij fenitoina, fenobarbitala in drugih antikonvulzivov, ki so substrati za izoencime cyp450.
there is a potential for reduction or increase in the plasma concentrations of phenytoin, phenobarbital and other anticonvulsants that are substrates of cyp450 isoenzymes when co- administered with efavirenz.

zdi se, da rufinamid ni klinično pomembno vplival na koncentracije karbamazepina, lamotrigina, fenobarbitala, topiramata, fenitoina ali valproata v stanju dinamičnega ravnovesja.
rufinamide appears not to have a clinically relevant effect on carbamazepine, lamotrigine, phenobarbital, topiramate, phenytoin or valproate steady state concentrations.

uporaba induktorjev cyp3a4, npr. karbamazepina, deksametazona, fenobarbitala, fenitoina ali rifampicina, lahko zmanjša vpliv zdravila qtern na znižanje glukoze v krvi.
using cyp3a4 inducers like carbamazepine, dexamethasone, phenobarbital, phenytoin, and rifampicin may reduce the glycaemic lowering effect of qtern.

koncentracijo rivaroksabana v plazmi lahko zmanjša tudi sočasna uporaba drugih močnih induktorjev cyp3a4 (npr. fenitoina, karbamazepina, fenobarbitala ali šentjanževke).
john’ s wort) may also lead to reduced rivaroxaban plasma concentrations.

stiripentol zveča učinkovitost ostalih antikonvulzivov (npr. karbamazepina, natrijevega valproata, fenitoina, fenobarbitala in številnih benzodiazepinov) kot posledica farmakokinetičnih interakcij.
stiripentol potentiates the efficacy of other anticonvulsants, such as carbamazepine, sodium valproate, phenytoin, phenobarbital and many benzodiazepines, as the result of pharmacokinetic interactions.

analiza populacijske farmakokinetike v preskušanjih 2. faze je pokazala, da sočasna uporaba deksametazona, proklorperazina, fenitoina, karbamazepina, ondansetrona, antagonistov receptorjev h2 ali fenobarbitala ne spremeni očistka tmz.
based on an analysis of population pharmacokinetics in phase ii trials, co-administration of dexamethasone, prochlorperazine, phenytoin, carbamazepine, ondansetron, h2 receptor antagonists, or phenobarbital did not alter the clearance of tmz.

sočasna uporaba fesoterodina in močnih induktorjev cyp3a4 (tj. karbamazepina, rifampicina, fenobarbitala, fenitoina, šentjanževke) ni priporočljiva (glejte poglavje 4.5).
the concomitant use of fesoterodine with a potent cyp3a4 inducer (i.e. carbamazepine, rifampicin, phenobarbital, phenytoin, st john’s wort) is not recommended (see section 4.5).